Benjamin Paluch

Stock Analyst at Roth MKM

(1.35)

# 3,408

Out of 4,876 analysts

3

Total ratings

33.33%

Success rate

0.17%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$25.95	+150.48%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$9.33	+82.21%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$3.00	+233.33%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $25.95

Upside: +150.48%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $9.33

Upside: +82.21%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $3.00

Upside: +233.33%